nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—UGT2B7—Chenodeoxycholic acid—primary biliary cirrhosis	0.333	0.597	CbGbCtD
Naproxen—ALB—primary biliary cirrhosis	0.236	1	CbGaD
Naproxen—SLCO1A2—Ursodeoxycholic acid—primary biliary cirrhosis	0.153	0.274	CbGbCtD
Naproxen—CYP2C8—Colchicine—primary biliary cirrhosis	0.0427	0.0764	CbGbCtD
Naproxen—CYP2C9—Colchicine—primary biliary cirrhosis	0.0298	0.0533	CbGbCtD
Naproxen—Indomethacin—ABCC2—primary biliary cirrhosis	0.000583	0.35	CrCbGaD
Naproxen—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000523	0.00293	CcSEcCtD
Naproxen—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000523	0.00293	CcSEcCtD
Naproxen—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.000523	0.00292	CcSEcCtD
Naproxen—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000518	0.0029	CcSEcCtD
Naproxen—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000518	0.0029	CcSEcCtD
Naproxen—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000518	0.0029	CcSEcCtD
Naproxen—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00287	CcSEcCtD
Naproxen—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00287	CcSEcCtD
Naproxen—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00051	0.00286	CcSEcCtD
Naproxen—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00051	0.00286	CcSEcCtD
Naproxen—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000502	0.00281	CcSEcCtD
Naproxen—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000502	0.00281	CcSEcCtD
Naproxen—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00274	CcSEcCtD
Naproxen—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00048	0.00269	CcSEcCtD
Naproxen—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00048	0.00269	CcSEcCtD
Naproxen—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00267	CcSEcCtD
Naproxen—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000477	0.00267	CcSEcCtD
Naproxen—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000476	0.00267	CcSEcCtD
Naproxen—Stomatitis—Colchicine—primary biliary cirrhosis	0.000474	0.00265	CcSEcCtD
Naproxen—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00264	CcSEcCtD
Naproxen—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00264	CcSEcCtD
Naproxen—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00263	CcSEcCtD
Naproxen—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00263	CcSEcCtD
Naproxen—Haematuria—Colchicine—primary biliary cirrhosis	0.000463	0.00259	CcSEcCtD
Naproxen—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00256	CcSEcCtD
Naproxen—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00256	CcSEcCtD
Naproxen—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.000454	0.00254	CcSEcCtD
Naproxen—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00253	CcSEcCtD
Naproxen—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00253	CcSEcCtD
Naproxen—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000447	0.0025	CcSEcCtD
Naproxen—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000447	0.0025	CcSEcCtD
Naproxen—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00248	CcSEcCtD
Naproxen—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00248	CcSEcCtD
Naproxen—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000439	0.00246	CcSEcCtD
Naproxen—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000439	0.00246	CcSEcCtD
Naproxen—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000435	0.00244	CcSEcCtD
Naproxen—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000435	0.00244	CcSEcCtD
Naproxen—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00241	CcSEcCtD
Naproxen—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00241	CcSEcCtD
Naproxen—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000429	0.0024	CcSEcCtD
Naproxen—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000429	0.0024	CcSEcCtD
Naproxen—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000428	0.0024	CcSEcCtD
Naproxen—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000428	0.0024	CcSEcCtD
Naproxen—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000426	0.00238	CcSEcCtD
Naproxen—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000426	0.00238	CcSEcCtD
Naproxen—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00238	CcSEcCtD
Naproxen—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00238	CcSEcCtD
Naproxen—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00238	CcSEcCtD
Naproxen—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00238	CcSEcCtD
Naproxen—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00234	CcSEcCtD
Naproxen—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00234	CcSEcCtD
Naproxen—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00233	CcSEcCtD
Naproxen—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00233	CcSEcCtD
Naproxen—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00231	CcSEcCtD
Naproxen—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00231	CcSEcCtD
Naproxen—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00231	CcSEcCtD
Naproxen—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000412	0.00231	CcSEcCtD
Naproxen—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00229	CcSEcCtD
Naproxen—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00041	0.00229	CcSEcCtD
Naproxen—Eye disorder—Colchicine—primary biliary cirrhosis	0.000408	0.00228	CcSEcCtD
Naproxen—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00221	CcSEcCtD
Naproxen—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000394	0.00221	CcSEcCtD
Naproxen—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000393	0.0022	CcSEcCtD
Naproxen—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.0022	CcSEcCtD
Naproxen—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.0022	CcSEcCtD
Naproxen—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00219	CcSEcCtD
Naproxen—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00219	CcSEcCtD
Naproxen—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00218	CcSEcCtD
Naproxen—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00218	CcSEcCtD
Naproxen—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00217	CcSEcCtD
Naproxen—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000387	0.00217	CcSEcCtD
Naproxen—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00216	CcSEcCtD
Naproxen—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00216	CcSEcCtD
Naproxen—Alopecia—Colchicine—primary biliary cirrhosis	0.000386	0.00216	CcSEcCtD
Naproxen—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00216	CcSEcCtD
Naproxen—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00216	CcSEcCtD
Naproxen—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00215	CcSEcCtD
Naproxen—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000384	0.00215	CcSEcCtD
Naproxen—Malnutrition—Colchicine—primary biliary cirrhosis	0.00038	0.00213	CcSEcCtD
Naproxen—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00211	CcSEcCtD
Naproxen—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00211	CcSEcCtD
Naproxen—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00205	CcSEcCtD
Naproxen—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00205	CcSEcCtD
Naproxen—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00205	CcSEcCtD
Naproxen—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00205	CcSEcCtD
Naproxen—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000365	0.00204	CcSEcCtD
Naproxen—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00204	CcSEcCtD
Naproxen—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00204	CcSEcCtD
Naproxen—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00199	CcSEcCtD
Naproxen—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000356	0.00199	CcSEcCtD
Naproxen—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00198	CcSEcCtD
Naproxen—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00198	CcSEcCtD
Naproxen—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00198	CcSEcCtD
Naproxen—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00198	CcSEcCtD
Naproxen—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00197	CcSEcCtD
Naproxen—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00197	CcSEcCtD
Naproxen—Anaemia—Colchicine—primary biliary cirrhosis	0.000351	0.00196	CcSEcCtD
Naproxen—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00196	CcSEcCtD
Naproxen—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00196	CcSEcCtD
Naproxen—Angioedema—Colchicine—primary biliary cirrhosis	0.000347	0.00194	CcSEcCtD
Naproxen—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000346	0.00194	CcSEcCtD
Naproxen—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000346	0.00194	CcSEcCtD
Naproxen—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00191	CcSEcCtD
Naproxen—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000341	0.00191	CcSEcCtD
Naproxen—Leukopenia—Colchicine—primary biliary cirrhosis	0.00034	0.0019	CcSEcCtD
Naproxen—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000336	0.00188	CcSEcCtD
Naproxen—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000336	0.00188	CcSEcCtD
Naproxen—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00187	CcSEcCtD
Naproxen—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00187	CcSEcCtD
Naproxen—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00186	CcSEcCtD
Naproxen—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00186	CcSEcCtD
Naproxen—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00184	CcSEcCtD
Naproxen—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00184	CcSEcCtD
Naproxen—Myalgia—Colchicine—primary biliary cirrhosis	0.000323	0.00181	CcSEcCtD
Naproxen—Arthralgia—Colchicine—primary biliary cirrhosis	0.000323	0.00181	CcSEcCtD
Naproxen—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000317	0.00177	CcSEcCtD
Naproxen—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000317	0.00177	CcSEcCtD
Naproxen—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00177	CcSEcCtD
Naproxen—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00177	CcSEcCtD
Naproxen—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00175	CcSEcCtD
Naproxen—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00175	CcSEcCtD
Naproxen—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000308	0.00172	CcSEcCtD
Naproxen—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000308	0.00172	CcSEcCtD
Naproxen—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00172	CcSEcCtD
Naproxen—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00172	CcSEcCtD
Naproxen—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000306	0.00171	CcSEcCtD
Naproxen—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000306	0.00171	CcSEcCtD
Naproxen—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00171	CcSEcCtD
Naproxen—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00171	CcSEcCtD
Naproxen—Shock—Colchicine—primary biliary cirrhosis	0.000305	0.00171	CcSEcCtD
Naproxen—Fenoprofen—ALB—primary biliary cirrhosis	0.000305	0.183	CrCbGaD
Naproxen—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000304	0.0017	CcSEcCtD
Naproxen—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000304	0.0017	CcSEcCtD
Naproxen—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00169	CcSEcCtD
Naproxen—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000302	0.00169	CcSEcCtD
Naproxen—Skin disorder—Colchicine—primary biliary cirrhosis	0.000301	0.00169	CcSEcCtD
Naproxen—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00168	CcSEcCtD
Naproxen—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00168	CcSEcCtD
Naproxen—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00167	CcSEcCtD
Naproxen—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00167	CcSEcCtD
Naproxen—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00165	CcSEcCtD
Naproxen—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000296	0.00165	CcSEcCtD
Naproxen—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00165	CcSEcCtD
Naproxen—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000295	0.00165	CcSEcCtD
Naproxen—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000291	0.00163	CcSEcCtD
Naproxen—Hypotension—Colchicine—primary biliary cirrhosis	0.00029	0.00162	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00161	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00161	CcSEcCtD
Naproxen—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00161	CcSEcCtD
Naproxen—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00161	CcSEcCtD
Naproxen—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000284	0.00159	CcSEcCtD
Naproxen—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000284	0.00159	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000282	0.00158	CcSEcCtD
Naproxen—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00157	CcSEcCtD
Naproxen—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00157	CcSEcCtD
Naproxen—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00156	CcSEcCtD
Naproxen—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00156	CcSEcCtD
Naproxen—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00155	CcSEcCtD
Naproxen—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00155	CcSEcCtD
Naproxen—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00153	CcSEcCtD
Naproxen—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00153	CcSEcCtD
Naproxen—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00153	CcSEcCtD
Naproxen—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00153	CcSEcCtD
Naproxen—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00153	CcSEcCtD
Naproxen—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00153	CcSEcCtD
Naproxen—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00152	CcSEcCtD
Naproxen—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00152	CcSEcCtD
Naproxen—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000271	0.00151	CcSEcCtD
Naproxen—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000271	0.00151	CcSEcCtD
Naproxen—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000269	0.00151	CcSEcCtD
Naproxen—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00151	CcSEcCtD
Naproxen—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00151	CcSEcCtD
Naproxen—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000268	0.0015	CcSEcCtD
Naproxen—Fatigue—Colchicine—primary biliary cirrhosis	0.000267	0.0015	CcSEcCtD
Naproxen—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00149	CcSEcCtD
Naproxen—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00149	CcSEcCtD
Naproxen—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00146	CcSEcCtD
Naproxen—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00026	0.00146	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00142	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000254	0.00142	CcSEcCtD
Naproxen—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000253	0.00142	CcSEcCtD
Naproxen—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00141	CcSEcCtD
Naproxen—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000252	0.00141	CcSEcCtD
Naproxen—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00025	0.0014	CcSEcCtD
Naproxen—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00025	0.0014	CcSEcCtD
Naproxen—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00139	CcSEcCtD
Naproxen—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00139	CcSEcCtD
Naproxen—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00139	CcSEcCtD
Naproxen—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00139	CcSEcCtD
Naproxen—Urticaria—Colchicine—primary biliary cirrhosis	0.000246	0.00138	CcSEcCtD
Naproxen—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00137	CcSEcCtD
Naproxen—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00137	CcSEcCtD
Naproxen—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000245	0.00137	CcSEcCtD
Naproxen—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00136	CcSEcCtD
Naproxen—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00136	CcSEcCtD
Naproxen—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00135	CcSEcCtD
Naproxen—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00135	CcSEcCtD
Naproxen—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00134	CcSEcCtD
Naproxen—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00134	CcSEcCtD
Naproxen—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00133	CcSEcCtD
Naproxen—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00133	CcSEcCtD
Naproxen—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00133	CcSEcCtD
Naproxen—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000238	0.00133	CcSEcCtD
Naproxen—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00128	CcSEcCtD
Naproxen—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00128	CcSEcCtD
Naproxen—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000228	0.00128	CcSEcCtD
Naproxen—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00127	CcSEcCtD
Naproxen—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00127	CcSEcCtD
Naproxen—Indomethacin—ALB—primary biliary cirrhosis	0.000225	0.135	CrCbGaD
Naproxen—Asthenia—Colchicine—primary biliary cirrhosis	0.000222	0.00124	CcSEcCtD
Naproxen—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00124	CcSEcCtD
Naproxen—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00124	CcSEcCtD
Naproxen—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00123	CcSEcCtD
Naproxen—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00123	CcSEcCtD
Naproxen—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00123	CcSEcCtD
Naproxen—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00123	CcSEcCtD
Naproxen—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000212	0.00119	CcSEcCtD
Naproxen—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00115	CcSEcCtD
Naproxen—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00115	CcSEcCtD
Naproxen—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0002	0.00112	CcSEcCtD
Naproxen—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0002	0.00112	CcSEcCtD
Naproxen—Flurbiprofen—ALB—primary biliary cirrhosis	0.000199	0.119	CrCbGaD
Naproxen—Vomiting—Colchicine—primary biliary cirrhosis	0.000197	0.0011	CcSEcCtD
Naproxen—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000197	0.0011	CcSEcCtD
Naproxen—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000197	0.0011	CcSEcCtD
Naproxen—Rash—Colchicine—primary biliary cirrhosis	0.000195	0.00109	CcSEcCtD
Naproxen—Dermatitis—Colchicine—primary biliary cirrhosis	0.000195	0.00109	CcSEcCtD
Naproxen—Headache—Colchicine—primary biliary cirrhosis	0.000194	0.00109	CcSEcCtD
Naproxen—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000191	0.00107	CcSEcCtD
Naproxen—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000191	0.00107	CcSEcCtD
Naproxen—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00103	CcSEcCtD
Naproxen—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00103	CcSEcCtD
Naproxen—Nausea—Colchicine—primary biliary cirrhosis	0.000184	0.00103	CcSEcCtD
Naproxen—Ketoprofen—ALB—primary biliary cirrhosis	0.00018	0.108	CrCbGaD
Naproxen—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000177	0.000991	CcSEcCtD
Naproxen—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000177	0.000991	CcSEcCtD
Naproxen—Ibuprofen—ALB—primary biliary cirrhosis	0.000177	0.106	CrCbGaD
Naproxen—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000176	0.000983	CcSEcCtD
Naproxen—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000176	0.000983	CcSEcCtD
Naproxen—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000175	0.000982	CcSEcCtD
Naproxen—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000175	0.000982	CcSEcCtD
Naproxen—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000174	0.000977	CcSEcCtD
Naproxen—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000174	0.000977	CcSEcCtD
Naproxen—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000165	0.000926	CcSEcCtD
Naproxen—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000165	0.000926	CcSEcCtD
Naproxen—AKR1C3—Metabolism—DLAT—primary biliary cirrhosis	6.66e-05	0.00263	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	6.56e-05	0.00259	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.51e-05	0.00257	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	6.4e-05	0.00252	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	6.32e-05	0.00249	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—LBR—primary biliary cirrhosis	6.29e-05	0.00248	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.13e-05	0.00242	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL4—primary biliary cirrhosis	5.99e-05	0.00236	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—LBR—primary biliary cirrhosis	5.87e-05	0.00231	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	5.65e-05	0.00223	CbGpPWpGaD
Naproxen—AKR1C3—Disease—ELMO1—primary biliary cirrhosis	5.58e-05	0.0022	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	5.57e-05	0.0022	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	5.46e-05	0.00216	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.46e-05	0.00215	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	5.34e-05	0.00211	CbGpPWpGaD
Naproxen—CYP1A2—Phase II conjugation—GGT1—primary biliary cirrhosis	5.34e-05	0.00211	CbGpPWpGaD
Naproxen—ALB—Hemostasis—RAD51B—primary biliary cirrhosis	5.25e-05	0.00207	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	5.24e-05	0.00207	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	5.24e-05	0.00207	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—OGDH—primary biliary cirrhosis	5.22e-05	0.00206	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	5.17e-05	0.00204	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	5.02e-05	0.00198	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	5.02e-05	0.00198	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	4.89e-05	0.00193	CbGpPWpGaD
Naproxen—ALB—Hemostasis—PDE5A—primary biliary cirrhosis	4.88e-05	0.00193	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDH5—primary biliary cirrhosis	4.83e-05	0.0019	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	4.83e-05	0.0019	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	4.8e-05	0.00189	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—LBR—primary biliary cirrhosis	4.78e-05	0.00189	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NUP210—primary biliary cirrhosis	4.78e-05	0.00188	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	4.77e-05	0.00188	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—NOS2—primary biliary cirrhosis	4.72e-05	0.00186	CbGpPWpGaD
Naproxen—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	4.7e-05	0.00185	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PDHX—primary biliary cirrhosis	4.65e-05	0.00184	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCR5—primary biliary cirrhosis	4.65e-05	0.00183	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	4.59e-05	0.00181	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—OGDH—primary biliary cirrhosis	4.55e-05	0.00179	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	4.54e-05	0.00179	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—GGT1—primary biliary cirrhosis	4.49e-05	0.00177	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCB4—primary biliary cirrhosis	4.38e-05	0.00173	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—DLAT—primary biliary cirrhosis	4.38e-05	0.00173	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	4.27e-05	0.00169	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.25e-05	0.00168	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—OGDH—primary biliary cirrhosis	4.24e-05	0.00167	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.22e-05	0.00166	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	4.2e-05	0.00166	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	4.18e-05	0.00165	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	4.1e-05	0.00162	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PDHX—primary biliary cirrhosis	4.05e-05	0.0016	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NUP210—primary biliary cirrhosis	4e-05	0.00158	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.9e-05	0.00154	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	3.88e-05	0.00153	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—DLAT—primary biliary cirrhosis	3.81e-05	0.0015	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCB4—primary biliary cirrhosis	3.81e-05	0.0015	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	3.81e-05	0.0015	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LBR—primary biliary cirrhosis	3.8e-05	0.0015	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PDHX—primary biliary cirrhosis	3.78e-05	0.00149	CbGpPWpGaD
Naproxen—AKR1C3—Disease—GOT2—primary biliary cirrhosis	3.78e-05	0.00149	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ABCG2—primary biliary cirrhosis	3.72e-05	0.00147	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	3.65e-05	0.00144	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	3.62e-05	0.00143	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—DLAT—primary biliary cirrhosis	3.56e-05	0.0014	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCB4—primary biliary cirrhosis	3.56e-05	0.0014	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	3.51e-05	0.00138	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	3.49e-05	0.00138	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—OGDH—primary biliary cirrhosis	3.46e-05	0.00136	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	3.42e-05	0.00135	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	3.28e-05	0.00129	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.26e-05	0.00129	CbGpPWpGaD
Naproxen—AKR1C3—Disease—GOT1—primary biliary cirrhosis	3.26e-05	0.00129	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CTGF—primary biliary cirrhosis	3.19e-05	0.00126	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GOT2—primary biliary cirrhosis	3.16e-05	0.00125	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	3.12e-05	0.00123	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	3.12e-05	0.00123	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.12e-05	0.00123	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LBR—primary biliary cirrhosis	3.09e-05	0.00122	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PDHX—primary biliary cirrhosis	3.08e-05	0.00122	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	3.08e-05	0.00122	CbGpPWpGaD
Naproxen—ALB—Metabolism—LBR—primary biliary cirrhosis	3.07e-05	0.00121	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—primary biliary cirrhosis	3.04e-05	0.0012	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	2.92e-05	0.00115	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—DLAT—primary biliary cirrhosis	2.9e-05	0.00114	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCB4—primary biliary cirrhosis	2.9e-05	0.00114	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—OGDH—primary biliary cirrhosis	2.75e-05	0.00108	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GGT1—primary biliary cirrhosis	2.73e-05	0.00108	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GOT1—primary biliary cirrhosis	2.73e-05	0.00108	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	2.72e-05	0.00107	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.67e-05	0.00105	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NUP210—primary biliary cirrhosis	2.63e-05	0.00104	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	2.61e-05	0.00103	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	2.51e-05	0.000992	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.48e-05	0.000977	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PDHX—primary biliary cirrhosis	2.45e-05	0.000965	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCG2—primary biliary cirrhosis	2.44e-05	0.000964	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.43e-05	0.000959	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PPARGC1A—primary biliary cirrhosis	2.43e-05	0.000959	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.39e-05	0.000942	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.38e-05	0.000937	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DLAT—primary biliary cirrhosis	2.3e-05	0.000908	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCB4—primary biliary cirrhosis	2.3e-05	0.000908	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NUP210—primary biliary cirrhosis	2.29e-05	0.000903	CbGpPWpGaD
Naproxen—AKR1C3—Disease—HIF1A—primary biliary cirrhosis	2.27e-05	0.000895	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—OGDH—primary biliary cirrhosis	2.23e-05	0.000881	CbGpPWpGaD
Naproxen—ALB—Metabolism—OGDH—primary biliary cirrhosis	2.22e-05	0.000876	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.22e-05	0.000876	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.2e-05	0.000867	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	2.15e-05	0.000848	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NUP210—primary biliary cirrhosis	2.14e-05	0.000843	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCG2—primary biliary cirrhosis	2.13e-05	0.00084	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.12e-05	0.000836	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CTGF—primary biliary cirrhosis	2.1e-05	0.000827	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GOT2—primary biliary cirrhosis	2.08e-05	0.00082	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS2—primary biliary cirrhosis	2.06e-05	0.000814	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.05e-05	0.000808	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.02e-05	0.000795	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP3—primary biliary cirrhosis	2e-05	0.000791	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2e-05	0.00079	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD80—primary biliary cirrhosis	2e-05	0.00079	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	1.99e-05	0.000785	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCG2—primary biliary cirrhosis	1.99e-05	0.000784	CbGpPWpGaD
Naproxen—ALB—Metabolism—PDHX—primary biliary cirrhosis	1.98e-05	0.000781	CbGpPWpGaD
Naproxen—PTGS2—Disease—ELMO1—primary biliary cirrhosis	1.93e-05	0.00076	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—AGT—primary biliary cirrhosis	1.89e-05	0.000747	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCL5—primary biliary cirrhosis	1.89e-05	0.000746	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.89e-05	0.000744	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	1.87e-05	0.000738	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	1.87e-05	0.000738	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.87e-05	0.000736	CbGpPWpGaD
Naproxen—ALB—Metabolism—DLAT—primary biliary cirrhosis	1.86e-05	0.000734	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCB4—primary biliary cirrhosis	1.86e-05	0.000734	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.85e-05	0.00073	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.83e-05	0.000723	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CTGF—primary biliary cirrhosis	1.83e-05	0.00072	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	1.82e-05	0.000717	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GOT2—primary biliary cirrhosis	1.81e-05	0.000714	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GGT1—primary biliary cirrhosis	1.79e-05	0.000708	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GOT1—primary biliary cirrhosis	1.79e-05	0.000708	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.77e-05	0.0007	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NUP210—primary biliary cirrhosis	1.74e-05	0.000687	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.72e-05	0.00068	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.71e-05	0.000676	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CTGF—primary biliary cirrhosis	1.7e-05	0.000672	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TYK2—primary biliary cirrhosis	1.69e-05	0.000667	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GOT2—primary biliary cirrhosis	1.69e-05	0.000666	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.67e-05	0.000658	CbGpPWpGaD
Naproxen—PTGS2—Disease—NUP210—primary biliary cirrhosis	1.65e-05	0.000651	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.64e-05	0.000647	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	1.62e-05	0.000639	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCG2—primary biliary cirrhosis	1.62e-05	0.000639	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARGC1A—primary biliary cirrhosis	1.6e-05	0.00063	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.59e-05	0.000627	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—AGT—primary biliary cirrhosis	1.58e-05	0.000624	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GOT1—primary biliary cirrhosis	1.56e-05	0.000616	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GGT1—primary biliary cirrhosis	1.56e-05	0.000616	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	1.55e-05	0.000613	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.53e-05	0.000605	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.53e-05	0.000602	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	1.52e-05	0.000601	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	1.52e-05	0.000601	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.47e-05	0.000579	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GGT1—primary biliary cirrhosis	1.46e-05	0.000575	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GOT1—primary biliary cirrhosis	1.46e-05	0.000575	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—primary biliary cirrhosis	1.45e-05	0.000573	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.42e-05	0.00056	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.4e-05	0.000553	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CD80—primary biliary cirrhosis	1.4e-05	0.000553	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.4e-05	0.000553	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.39e-05	0.000548	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CTGF—primary biliary cirrhosis	1.39e-05	0.000548	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.38e-05	0.000546	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NUP210—primary biliary cirrhosis	1.38e-05	0.000545	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GOT2—primary biliary cirrhosis	1.38e-05	0.000543	CbGpPWpGaD
Naproxen—PTGS2—Disease—GOT2—primary biliary cirrhosis	1.31e-05	0.000515	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.3e-05	0.000514	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.3e-05	0.000514	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.3e-05	0.000512	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCG2—primary biliary cirrhosis	1.29e-05	0.000507	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.25e-05	0.000493	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—AGT—primary biliary cirrhosis	1.24e-05	0.000491	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.2e-05	0.000473	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.19e-05	0.000471	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.19e-05	0.00047	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GOT1—primary biliary cirrhosis	1.19e-05	0.000469	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GGT1—primary biliary cirrhosis	1.19e-05	0.000469	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.19e-05	0.000469	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TYK2—primary biliary cirrhosis	1.18e-05	0.000467	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.13e-05	0.000445	CbGpPWpGaD
Naproxen—PTGS2—Disease—GOT1—primary biliary cirrhosis	1.13e-05	0.000444	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	1.13e-05	0.000444	CbGpPWpGaD
Naproxen—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.12e-05	0.000441	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CTGF—primary biliary cirrhosis	1.1e-05	0.000435	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GOT2—primary biliary cirrhosis	1.09e-05	0.000431	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—AGT—primary biliary cirrhosis	1.08e-05	0.000427	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.07e-05	0.000421	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.06e-05	0.000417	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	1.05e-05	0.000413	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.04e-05	0.00041	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—AGT—primary biliary cirrhosis	1.01e-05	0.000399	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9.72e-06	0.000384	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—primary biliary cirrhosis	9.54e-06	0.000376	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GOT1—primary biliary cirrhosis	9.44e-06	0.000372	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GGT1—primary biliary cirrhosis	9.44e-06	0.000372	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—primary biliary cirrhosis	9.32e-06	0.000368	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.22e-06	0.000364	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9.17e-06	0.000362	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	9.16e-06	0.000361	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	8.97e-06	0.000354	CbGpPWpGaD
Naproxen—ALB—Metabolism—CTGF—primary biliary cirrhosis	8.92e-06	0.000352	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	8.89e-06	0.000351	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT2—primary biliary cirrhosis	8.84e-06	0.000349	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	8.51e-06	0.000336	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARGC1A—primary biliary cirrhosis	8.4e-06	0.000331	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—primary biliary cirrhosis	8.31e-06	0.000328	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	8.31e-06	0.000328	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—AGT—primary biliary cirrhosis	8.24e-06	0.000325	CbGpPWpGaD
Naproxen—PTGS2—Disease—HIF1A—primary biliary cirrhosis	7.84e-06	0.000309	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	7.82e-06	0.000309	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—primary biliary cirrhosis	7.76e-06	0.000306	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	7.68e-06	0.000303	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	7.68e-06	0.000303	CbGpPWpGaD
Naproxen—ALB—Metabolism—GOT1—primary biliary cirrhosis	7.63e-06	0.000301	CbGpPWpGaD
Naproxen—ALB—Metabolism—GGT1—primary biliary cirrhosis	7.63e-06	0.000301	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	7.46e-06	0.000294	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	7.3e-06	0.000288	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	7.27e-06	0.000287	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	7.24e-06	0.000286	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS2—primary biliary cirrhosis	7.13e-06	0.000281	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD80—primary biliary cirrhosis	6.92e-06	0.000273	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	6.83e-06	0.00027	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	6.79e-06	0.000268	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—AGT—primary biliary cirrhosis	6.54e-06	0.000258	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.38e-06	0.000252	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—primary biliary cirrhosis	6.32e-06	0.000249	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	6.25e-06	0.000246	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	6.25e-06	0.000246	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	6.24e-06	0.000246	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	6.19e-06	0.000244	CbGpPWpGaD
Naproxen—PTGS2—Disease—TYK2—primary biliary cirrhosis	5.84e-06	0.00023	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	5.56e-06	0.000219	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	5.34e-06	0.000211	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	5.34e-06	0.000211	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	5.32e-06	0.00021	CbGpPWpGaD
Naproxen—ALB—Metabolism—AGT—primary biliary cirrhosis	5.29e-06	0.000209	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—primary biliary cirrhosis	5.02e-06	0.000198	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	4.75e-06	0.000187	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	4.33e-06	0.000171	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	4.08e-06	0.000161	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	3.7e-06	0.000146	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	3.32e-06	0.000131	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	2.84e-06	0.000112	CbGpPWpGaD
